Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies, today announced it was awarded a group
purchasing organization (GPO) agreement with Premier®, Inc. for the
Titan SGS® powered stapling device, expanding access to this
innovative technology for surgeons affiliated with Premier.
The Titan SGS® device is a sterile, single patient use
instrument used for longitudinal transection and resection of the
gastric tissue for sleeve gastrectomy pouch creation.1 It is the
only stapler available in the United States with a specific
indication for sleeve pouch creation in bariatric procedures. The
GPO agreement allows Premier members, at their discretion, the
opportunity to take advantage of special pricing and terms
pre-negotiated by Premier for the Titan SGS® device.
“It’s an honor to be selected as a supplier for Premier. They
are committed to providing innovative medical devices to surgeons
and healthcare providers. We are excited to work with them to
provide the advanced technology of Titan SGS®,” said James
Ferguson, President and General Manager, Surgical, Teleflex.
The Titan SGS® powered stapling device offers a range of
benefits:
- Shown to cut
stapling time for a sleeve gastrectomy in half with one 55-second
firing sequence2,3
- Helps surgeons
deliver a more consistent and repeatable gastric sleeve anatomy
with the industry’s longest continuous staple line of 23cm with no
overlapping staples3
- Because it has been
shown to take approximately half the time to create the staple line
compared to existing short cartridge linear staplers,2,4 it can
also potentially improve procedure time and operational
efficiencies3,4
More than 6,000 sleeve gastrectomy procedures—laparoscopic and
robotic-assisted—have been completed across the United States using
Titan SGS® technology since its introduction to the market in
2021.
“We are thrilled Premier awarded Teleflex this contract for the
Titan SGS®. We see this as another opportunity to put the
transformational technology of Titan SGS® into the hands of
bariatric surgeons across the country,” said Ronald Galovich, Vice
President, Marketing & Sales, Surgical, Teleflex
Incorporated.
Surgeons interested in learning more about Titan SGS® device or
to request training can visit
https://education.standardbariatrics.com/.
Premier is a leading healthcare improvement company, uniting an
alliance of approximately 4,400 U.S. hospitals and 250,000 other
providers to transform healthcare. With integrated data and
analytics, collaboratives, supply chain solutions,
consulting and other services, Premier enables better care and
outcomes at a lower cost.
About Teleflex IncorporatedTeleflex is a global
provider of medical technologies designed to improve the health and
quality of people’s lives. We apply purpose driven innovation – a
relentless pursuit of identifying unmet clinical needs – to benefit
patients and healthcare providers. Our portfolio is diverse, with
solutions in the fields of vascular access, interventional
cardiology and radiology, anesthesia, emergency medicine, surgical,
urology and respiratory care. Teleflex employees worldwide are
united in the understanding that what we do every day makes a
difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®,
QuikClot®, Rüsch®, UroLift®, and Weck® – trusted brands united by a
common sense of purpose.
About Standard Bariatrics, Inc.Standard
Bariatrics, Inc., now part of Teleflex, is focused on the
development and commercialization of products for the surgical
treatment of obesity. Driven by a passionate group of surgical
innovators, the organization works hand in hand with bariatric
surgeons to develop and release novel solutions designed to address
the growing global epidemic of obesity. The team offers extensive
experience in creating and bringing to market bariatric-related
medical device technologies. They have a demonstrated record of
achieving clinical excellence with economically responsible
solutions for providers and their patients.
Forward-Looking StatementsAny statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which
may cause actual results or company actions to differ materially
from what is expressed or implied by these statements. These risks
and uncertainties are identified and described in more detail in
our filings with the Securities and Exchange Commission, including
our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, LMA, Pilling,
QuikClot, Rüsch, Titan SGS, Standard Bariatrics, UroLift, and Weck
are trademarks or registered trademarks of Teleflex Incorporated or
its affiliates, in the U.S. and/or other countries. © 2023 Teleflex
Incorporated. All rights reserved.
References:1510(k) No. K210278. 28 Apr 2021.
Retrieved from
https://www.accessdata.fda.gov/cdrh_docs/pdf21/K210278.pdf
2Standard Bariatrics, Inc., Section 510(k) Premarket
Notification Submission for Titan SGS. Prepared 28 Jan 2021.
3Salyer, C. E., Thompson, J., Hoffman, A., Burstein, M. D.,
Enochs, P., Watkins, B. M., Kuethe, J., & Goodman, M. D.
(2022). Multisite Study of Titan SGS Stapler in longitudinal
gastric resection. Surgical Endoscopy.
https://doi.org/10.1007/s00464-022-09051-x
4Varban, O. A., Niemann, A., Stricklen, A., Ross, R., Ghaferi,
A. A., Finks, J. F., & Dimick, J. B. (Aug 2017). Far from
Standardized: Using Surgical Videos to Identify Variation in
Technique for Laparoscopic Sleeve Gastrectomy. Journal of
Laparoendoscopic & Advanced Surgical Techniques. Part
A, 27(8), 761–767. https://doi.org/10.1089/lap.2017.0184
Contacts:Teleflex
Lawrence KeuschVice President, Investor Relations and Strategy
Development
John Hsu, CFAVice President, Investor Relations
investor.relations@teleflex.com610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Jul 2023 to Jul 2024